-
-
公开(公告)号:JPWO2006049211A1
公开(公告)日:2008-05-29
申请号:JP2006542425
申请日:2005-11-02
申请人: 国立大学法人富山大学
IPC分类号: C07C67/307 , C07C57/58 , C07C59/68 , C07C59/88 , C07C69/65 , C07C69/734 , C07C69/738 , C07D317/30 , C07D317/72 , C07D337/14 , C07D491/052
CPC分类号: C07C67/307 , C07B2200/07 , C07C51/09 , C07C2601/08 , Y02P20/55 , C07C57/58 , C07C69/65 , C07C69/734 , C07C69/738 , C07C69/736
摘要: 本発明は、以下のスキームで示される2−アリール−2−フルオロアルカン酸エステルを短工程、高収率で製造する方法及び該方法等で製造される新規な2−アリール−2−フルオロアルカン酸類に係るものである。本発明で製造されるキラル中心にフッ素原子が導入された化合物は、解熱・鎮痛・消炎薬の薬理作用の増強、副作用の低減や、新規な光学分割剤、液晶原料などとして有用である。【化1】(式中、Arは置換されていてもよいアリール基等を;Raはカルボキシル保護基を;R1は置換されていてもよいアルキル基を、それぞれ意味する。)
-
公开(公告)号:JP3701878B2
公开(公告)日:2005-10-05
申请号:JP2001073708
申请日:2001-03-15
申请人: 塩野義製薬株式会社
IPC分类号: C07D295/18 , A61K31/5575 , A61K31/5585 , A61K31/559 , A61P11/02 , A61P37/08 , A61P43/00 , C07C311/20 , C07C311/29 , C07C311/37 , C07C311/43 , C07D207/34 , C07D209/30 , C07D209/42 , C07D209/88 , C07D213/34 , C07D213/81 , C07D213/82 , C07D221/10 , C07D235/06 , C07D257/04 , C07D261/18 , C07D263/56 , C07D271/10 , C07D275/02 , C07D277/20 , C07D277/34 , C07D277/36 , C07D277/54 , C07D277/56 , C07D279/22 , C07D285/06 , C07D307/56 , C07D307/85 , C07D307/91 , C07D311/12 , C07D311/24 , C07D311/82 , C07D313/14 , C07D317/44 , C07D319/24 , C07D333/18 , C07D333/34 , C07D333/38 , C07D333/62 , C07D333/70 , C07D333/76 , C07D337/14
-
公开(公告)号:JP2005139120A
公开(公告)日:2005-06-02
申请号:JP2003377810
申请日:2003-11-07
申请人: Ohara Yakuhin Kogyo Kk , 大原薬品工業株式会社
发明人: NAKADA YOSHITAKA
IPC分类号: C07D337/14 , C07B61/00 , C07C319/20 , C07C323/63
摘要: PROBLEM TO BE SOLVED: To provide a method for industrially advantageously producing zaltoprofen as an anti-inflammatory/analgesic agent.
SOLUTION: The method comprises the following process: Zinc iodide, sodium cyanide or potassium cyanide, and trimethylsilyl chloride are added to a compound of formula(I) followed by mixing them together to carry out a reaction to form a compound of formula(II). Sodium cyanide or potassium cyanide, trimethylsilyl chloride, acetonitrile and water are added to the compound of formula(II) followed by mixing them together to carry out a reaction to form a compound of formula(III). Polyphosphoric acid is made to act on the compound of formula(III) to effect cyclization, followed by addition of water to form a compound of formula(IV), which is then hydrolyzed to obtain the objective compound(zaltoprofen) of formula(V). In the above formulas, R is a lower alkyl.
COPYRIGHT: (C)2005,JPO&NCIPI摘要翻译: 待解决的问题:提供一种在工业上有利地制备作为抗炎/止痛剂的扎洛芬的方法。 解决方案:该方法包括以下过程:将碘化锌,氰化钠或氰化钾和三甲基甲硅烷基氯加入到式(I)化合物中,然后将它们混合在一起进行反应,形成式 (II)。 将氰化钠或氰化钾,三甲基甲硅烷基氯,乙腈和水加入到式(II)化合物中,然后将它们混合在一起进行反应以形成式(III)化合物。 使多磷酸作用于式(III)化合物进行环化,然后加入水形成式(IV)化合物,然后将其水解,得到式(V)的目标化合物(zaltoprofen) 。 在上式中,R为低级烷基。 版权所有(C)2005,JPO&NCIPI
-
公开(公告)号:JPWO2002036583A1
公开(公告)日:2004-03-11
申请号:JP2002539342
申请日:2001-10-26
申请人: 塩野義製薬株式会社
IPC分类号: C07D207/34 , A61K31/343 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/404 , A61K31/407 , A61P11/02 , A61P27/14 , A61P37/08 , A61P43/00 , C07D209/42 , C07D307/79 , C07D307/84 , C07D307/85 , C07D307/91 , C07D333/38 , C07D333/52 , C07D333/54 , C07D333/64 , C07D333/68 , C07D333/70 , C07D333/74 , C07D333/76 , C07D337/14 , C07D495/04
CPC分类号: C07D307/79 , C07D307/85 , C07D333/38 , C07D333/54 , C07D333/64 , C07D333/70 , C07D333/76 , C07D495/04
摘要: 代謝的に安定なPGD2受容体拮抗活性を有する化合物として、式(I):(式中、Yはビシクロ環;R1は置換されていてもよいヘテロアリール;R2は水素など;R3は−CH2−CH2−CH2−CH2−CH=CH−COOR4、−CH2−CH2−CH2−CH2−X1−CH2−COOR4、−CH2−CH=CH−CH2−X1−CH2−COOR4または−CH2−CH2−CH2−CH2−COOR4;R4は水素など;X1は−O−など。)で示される化合物を見出した。
-
公开(公告)号:JP3286056B2
公开(公告)日:2002-05-27
申请号:JP331994
申请日:1994-01-18
IPC分类号: C07D319/08 , A61K31/00 , A61K31/40 , A61K31/403 , A61K31/427 , A61K31/4355 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/445 , A61K31/4465 , A61K31/451 , A61K31/454 , A61K31/4545 , A61K31/47 , A61K31/473 , A61K31/4745 , A61K31/495 , A61K31/496 , A61K31/506 , A61K31/535 , A61K31/5377 , A61K31/538 , A61K31/54 , A61K31/5415 , A61K31/55 , A61K31/551 , A61P25/28 , A61P43/00 , C07D209/86 , C07D209/92 , C07D209/94 , C07D211/32 , C07D211/46 , C07D221/14 , C07D221/16 , C07D223/18 , C07D223/20 , C07D223/22 , C07D265/38 , C07D267/20 , C07D279/20 , C07D279/22 , C07D307/91 , C07D311/82 , C07D313/14 , C07D327/08 , C07D337/14 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/06 , C07D409/12 , C07D411/06 , C07D413/06 , C07D417/06 , C07D417/12 , C07D471/06 , C07D487/04 , C07D487/06 , C07D491/113
-
公开(公告)号:JP2612161B2
公开(公告)日:1997-05-21
申请号:JP13468286
申请日:1986-06-10
IPC分类号: C07D337/14 , C07C67/00 , C07C313/00 , C07C323/62 , C07D307/14
-
公开(公告)号:JPH0341022A
公开(公告)日:1991-02-21
申请号:JP17682589
申请日:1989-07-07
申请人: HOE YAKUKOU KK , PROD DEV RES INST
IPC分类号: C07D337/14 , A61K31/35 , A61K31/38 , A61P19/06 , C07D313/14
摘要: PURPOSE:To obtain a treating agent of hyperuricemia having low side effects specific to psychotropic agents, such as suppressive action on nervous system, comprising a dibenzothiepin (or debenzoxepin) derivative, which is novel except a part of the derivatives. CONSTITUTION:A treating agent of hyperuricemia which comprises a compound shown by formula I (Y is S or O; X is H, halogen or lower alkoxy; R is 3-4C alkylene; R and R are methyl or ethyl), such as 8-chloro-10-(3- dimethylaminopropoxy)dibenzo [b,f]thiepin or dibenzoxepin or a pharmaceutically acceptable salt as an active ingredient and can promote discharge of uric acid and urination without causing side effects such as dizziness, unsteadiness, sleepfulness, headache, weakness and malaise owing to the absence of suppressive action on nervous system frequently observed in similar well-known drug. The above-mentioned compound is obtained by reacting a compound shown by formula II with an alcohol reactive derivative shown by formula III.
-
公开(公告)号:JPH0141627B2
公开(公告)日:1989-09-06
申请号:JP6057877
申请日:1977-05-26
申请人: CIBA GEIGY
发明人: HANSU BURATSUTONA , ANGERO SUTORUNI
IPC分类号: A61K31/55 , A61P25/00 , A61P25/18 , A61P25/20 , C07D223/14 , C07D223/22 , C07D223/32 , C07D313/14 , C07D333/74 , C07D337/14 , C07D487/04 , C07D491/04 , C07D491/044 , C07D491/048 , C07D495/04 , C07D495/14
-
公开(公告)号:JPS631311B2
公开(公告)日:1988-01-12
申请号:JP6459679
申请日:1979-05-26
申请人: NIPPON CHEMIPHAR CO
发明人: FUJIMOTO YASUO , YAMABE SHIGERU
IPC分类号: C07D337/14 , A61K31/38 , A61P29/00
-
-
-
-
-
-
-
-
-